| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |